Sonexa Therapeutics

About:

Sonexa Therapeutics is a pharmaceutical company that develops drug treatments for Alzheimer's disease and related disorders.

Website: http://sonexa.com

Top Investors: Scale Venture Partners, Alta Partners, Domain Associates, Mitsubishi International Corporation (MIC), AgeChem Venture Fund

Description:

Sonexa Therapeutics, Inc., a pharmaceutical company, engages in the development of therapeutics drugs for the treatment of Alzheimer's disease and related disorders. It develops ST101, a small and orally active molecule compound that penetrates the blood-brain-barrier. The company was incorporated in 2007 and is based in San Diego, California.

Total Funding Amount:

$41.2M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)sonexa.com

Founders:

Eckard Weber

Number of Employees:

11-50

Last Funding Date:

2012-08-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai